Verition Fund Management
ACHN

Verition Fund Management’s Achillion Pharmaceuticals ACHN Stock Holding History

Verition Fund Management’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-25,865
Closed -$86K – 688
2013
Q4 		$86K Buy
+25,865
New +$75K 0.02% 458

Verition Fund Management's ACHN Position: Q1 2014 in Review

Verition Fund Management sold out of Achillion Pharmaceuticals (ACHN) in Q1 2014, closing a stake of 25,865 shares — an estimated $86K sold.

Verition Fund Management first reported a position in ACHN in Q4 2013 and held it in 1 quarter. The position peaked at $86K in Q4 2013. 94 funds tracked by Wall St. Rank hold ACHN as of Q1 2014.

  • Verition Fund Management reported no remaining Achillion Pharmaceuticals position as of Q1 2014 after selling out during the quarter.
  • Verition Fund Management sold 25,865 Achillion Pharmaceuticals shares in Q1 2014, an estimated $86K.
  • Verition Fund Management first reported a position in Achillion Pharmaceuticals in Q4 2013 and held it in 1 quarter.
  • Verition Fund Management's Achillion Pharmaceuticals position peaked at $86K in Q4 2013.
  • 94 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2014.

Based on Verition Fund Management's 13F filing for Q1 2014, filed 14 May 2014.